2020
DOI: 10.24251/hicss.2020.400
|View full text |Cite
|
Sign up to set email alerts
|

Beyond Data Markets: Opportunities and Challenges for Distributed Ledger Technology in Genomics

Abstract: During the past decade, distributed ledger technology (DLT) has found its way into application areas outside finance, such as supply chain management, the Internet of Things, or health care. To this end, this novel technology phenomenon has recently also caught the attention of researchers and practitioners in genomics. Although various DLT-based data markets for genome data already exist or are in development, the potential of DLT in this context is far from exhausted, whereas the possible risks related to th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 21 publications
(44 reference statements)
0
16
0
1
Order By: Relevance
“…In this context, DLT has emerged as a path to application development that enables interoperability between systems by providing secure and immutable information storage and exchange [13,53]. Examples of extant use cases are defined for the following areas of healthcare: pharma, biotechnology, medicine, insurance, genomics [2,68].…”
Section: Healthcare Sectormentioning
confidence: 99%
“…In this context, DLT has emerged as a path to application development that enables interoperability between systems by providing secure and immutable information storage and exchange [13,53]. Examples of extant use cases are defined for the following areas of healthcare: pharma, biotechnology, medicine, insurance, genomics [2,68].…”
Section: Healthcare Sectormentioning
confidence: 99%
“…Several studies explore the use of blockchain for registering and distributing DNA data. For instance, [Ozercan et al 2018] and [Thiebes et al 2020] discuss the potential that blockchain holds for genomics, whereas companies like Nebula Genomics [Grishin et al 2018] and Encrypgen [Encrypgen 2021] use the technology in their business model. However, these companies typically act as gatekeepers, centralizing the system and removing many of the advantages of decentralization (e.g., scalability and availability).…”
Section: Related Workmentioning
confidence: 99%
“…[98] Potential of blockchain in genomics and a use-case proposal. [110,124,125] Potential of blockchain in genomics.…”
Section: Table 1 Reviews On the Use Of Blockchain In Genomicsmentioning
confidence: 99%
“…For instance, [58] provided an overview of the current trends in using blockchain in healthcare and showed the properties of blockchain that are most commonly used, and [2] classified each work in applying blockchain in healthcare based on the use-case. Blockchain has also been proposed as a candidate approach to address many of the challenges in handling genomic data [98,110,124].…”
Section: Purpose and Objectivesmentioning
confidence: 99%